Austin Marcolina, DO
Pain Medicine · Holland, MINPI 1518463090
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 54.1% of the total. Reporting peaked in 2024 at $5,565 and has fallen 82.4% since, to $978 in 2025.
Across 86 payments — averaging $124.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Medtronic$3K
- Stryker$858
- Nevro Corp.$393
- SPR Therapeutics, Inc$196
- Globus Medical$183
- plus $544 from 9 others
What the payments were for
- Grants$1,66716%
- Travel & lodging$5,72453%
- Food & beverage$3,31631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $5,796 |
| Medtronic | 14 | $2,737 |
| Stryker | 10 | $858 |
| Nevro Corp. | 6 | $393 |
| SPR Therapeutics, Inc | 2 | $196 |
| Globus Medical | 2 | $183 |
| Relievant Medsystems, Inc. | 1 | $140 |
| Averitas Pharma Inc. | 1 | $127 |
| Boston Scientific | 2 | $80 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Pfizer | 2 | $49 |
| Painteq LLC | 1 | $38 |
| Zimmer Biomet | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$5,030
- SYNCHROMEDII$1,667
- INTELLIS ADAPTIVESTIM$813
- mild Device Kit$542
- Intracept$281
- CORRIDOR$176
- Omnia$135
- Senza$131
- Qutenza$127
- SPRINT PNS System$116
- SPINEJACK$105
How this compares
$10,706 in reported general payments places this provider in the 80th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 245 | $3,946 |
| Gabapentin | 198 | $2,770 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 67 | $1,469 |
| Morphine Sulfate ErMorphine Sulfate | 54 | $1,093 |
| Oxycodone Hcl | 47 | $771 |
| Pregabalin | 65 | $681 |
| Tizanidine Hcl | 84 | $676 |
| Duloxetine Hcl | 19 | $593 |
| Cyclobenzaprine Hcl | 61 | $510 |
| Celecoxib | 30 | $475 |
| Methadone Hcl | 31 | $381 |
| Methocarbamol | 45 | $330 |
| Topiramate | 27 | $277 |
| Trazodone Hcl | 28 | $274 |
| Propranolol Hcl | 16 | $267 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Holland
- Harry SukumaranRochester Hills$304K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$44K
- Alexander TurfeWyandotte$41K
- Kendall GroseWyandotte$26K
- Craig HartrickRoyal Oak$26K
- Patrick ForrestAnn Arbor$23K
- Anmar DalatiDetroit$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.